Atherosclerosis in the Coronary and Carotid Arteries
NCT00080587 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 125
Last updated 2008-03-04
Summary
This study will compare changes in atherosclerotic plaque in the coronary arteries (vessels on the surface of the heart that supply blood to the heart) with changes in the carotid arteries (vessels in the neck that supply blood to the brain) in patients enrolled in a Pfizer-sponsored treatment trial for coronary artery disease. Atherosclerosis is a buildup of fatty deposits (plaque) in arteries that can lead to blockage of the vessel, possibly resulting in heart attack or stroke. A major question in cardiovascular disease is how closely atherosclerotic changes in the coronary arteries correlate with changes in the carotid artery that occur with treatment. substudy of a Pfizer.
Patients enrolled in the Pfizer trial comparing the effectiveness of the drug atorvastatin with a combination of atorvastatin and CETP inhibitor (a drug to increase HDL cholesterol levels) may be eligible for this substudy.
Participants undergo magnetic resonance imaging (MRI) and ultrasound of the carotid arteries to measure the thickness of the vessels. The results are then compared with the coronary artery images obtained as part of the patient's evaluation for the Pfizer trial.
MRI
MRI scans use a powerful magnet with an advanced computer system and radio waves to produce accurate, detailed pictures of organs and tissues. During the scan the patient lies on a table in a narrow cylinder containing a magnetic field, wearing earplugs to muffle loud noises that occur with electrical switching of the magnetic fields. A medicine called gadolinium contrast may be injected into a vein during part of the scan to brighten the images. The scan takes about 30 to 90 minutes. An electrocardiogram (ECG) is done during the scan to monitor the heart's electrical activity. Patients who agree to undergo another MRI test are also imaged in a scanner that uses a stronger (3 Tesla) magnet.
Ultrasound
An echocardiogram (ultrasound of the heart) uses sound waves to image the carotid arteries. A gel is applied to the area of the neck to be imaged and a small handheld ultrasound probe is held against the neck to take the pictures.
Participants return after 2 years for a second set of tests.
Conditions
- Coronary Disease
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
lead NIH
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-04-30
- Completion
- 2005-01-31
Countries
- United States
Study Locations
More Related Trials
-
Cardiovascular Inflammation Reduction Trial
NCT01594333 ·Status: COMPLETED ·Phase: PHASE3
-
Carotid Plaque Regression With Statin Treatment Assessed by High Field Magnetic Resonance Imaging (MRI)
NCT00388843 ·Status: WITHDRAWN
-
Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)
NCT01178320 ·Status: COMPLETED
-
Proof of Mechanism Study of MLN1202 on Atherosclerotic Inflammation in Participants With Stable Atherosclerotic Cardiovascular Disease
NCT02388971 ·Status: WITHDRAWN ·Phase: PHASE2
-
Randomized Trial of Imaging Versus Risk Factor-Based Therapy for Plaque Regression
NCT01212900 ·Status: COMPLETED ·Phase: PHASE4
-
Lp-PLA2 and Coronary Atherosclerosis in Humans
NCT01557088 ·Status: COMPLETED ·Phase: NA
-
CER-001 Atherosclerosis Regression ACS Trial
NCT02484378 ·Status: COMPLETED ·Phase: PHASE2
-
Accelerated Atherosclerosis in High Risk Population Groups: An Assessment by Magnetic Resonance Imaging
NCT02114697 ·Status: TERMINATED ·Phase: PHASE4
-
Effect of Evolocumab on Coronary Atherosclerosis
NCT03689946 ·Status: COMPLETED ·Phase: PHASE3
-
Contribution of Hepatic and Intestinal Lipoproteins to Human Atherosclerosis
NCT01321476 ·Status: WITHDRAWN
-
Neuroinflammation in Asymptomatic Carotid Artery Disease - Imaging Substudy
NCT05238961 ·Status: WITHDRAWN ·Phase: PHASE1
-
Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Coronary Artery Disease
NCT00185042 ·Status: COMPLETED ·Phase: PHASE2
-
Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
NCT01327846 ·Status: COMPLETED ·Phase: PHASE3
-
Role of Mitophagy in Myeloid Cells During Coronary Atherosclerosis.
NCT05708547 ·Status: COMPLETED
-
Study Effect of VIA-2291 on Vascular Inflammation
NCT00358826 ·Status: COMPLETED ·Phase: PHASE2
-
A Study on the Impact of Bivalirudin Usage During PCI for High-risk Plaques on Post-PCI Coronary Microcirculation.
NCT05984537 ·Status: RECRUITING ·Phase: PHASE4
-
Carotid Atherosclerosis: MEtformin for Insulin ResistAnce Study
NCT00723307 ·Status: COMPLETED ·Phase: PHASE4
-
Aliskiren Effect on Aortic Plaque Progression
NCT01417104 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Study of microRNAs in the Evolution of Carotid Plaque. Physiopathological and Therapeutic Interest
NCT03149406 ·Status: UNKNOWN
-
Carotid IMT (Intima Media Thickening) Study (0524A-041)(TERMINATED)
NCT00384293 ·Status: TERMINATED ·Phase: PHASE3
-
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
NCT01059682 ·Status: TERMINATED ·Phase: PHASE3
-
ESCALATion of Medical Therapy Following Multimodality Plaque Evaluation in High-risk Chronic Coronary Syndromes
NCT06469528 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Efficacy and Safety of Pactimibe in Patients With Atherosclerosis
NCT00185146 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of Atherosclerotic Plaque Characteristics Change by DCE-MRI With Alirocumab
NCT02992301 ·Status: UNKNOWN ·Phase: PHASE4
-
Bacteria in Atherosclerotic Plaques and Adverse Events
NCT06935279 ·Status: COMPLETED